Government contracts

1. Agreement on the provision of subsidies from the “17” June 2014 №14.576.21.0010 with the Russian Ministry of Education in the framework of the Federal Target Program “Research and development in priority areas of Russian scientific and technological complex for 2014-2020” on the theme “Development of innovative technologies obtaining new functional food based on fat salmon fish (Salmonidae), have hepatoprotective, cardioprotective, immunomodulatory, anti-inflammatory and antioxidant properties “

 

Step number 1 (06/17/14 at 12/31/14)

 

Step number 2 (01.01.15 on 06.30.15)

 

The Commission has recognized the Russian Ministry of obligations under the Agreement on the reporting stage, executed properly.

2. Government contracts of “12” in August 2014 № 14411.2049999.19.052 with the Russian Ministry of Industry within the framework of the federal target program “Development of the Russian Federation the pharmaceutical and medical industry for the period up to 2020 and beyond” on the subject: “Pre-clinical drug research based on bisnaftazarina for the treatment of allergic and inflammatory diseases of the eye, “code” 2.1 Bisnaftazarin 2014 “.

Implementation of the project: Stage 4 (the final).

3. Government contracts from “20” August 2014 № 14411.2049999.19.068 with Russian Industry and Trade Ministry in the framework of the federal target program “Development of the Pharmaceutical and Medical Industry of the Russian Federation for the period up to 2020 and beyond” on the topic: “Preclinical studies on the basis of cardioprotective drug coenzyme Q10 for intravenous administration to correct myocardial acute ischemic conditions, “cipher” 2.1 acute ischemia of 2014 “.

Subcontractor – Lomonosov Moscow State University, Moscow.

Implementation of the project: Stage 4 (the final).

4. Government contracts on “04” September 2015 № 14.N08.12.1039 with the Russian Ministry of Education to conduct PNIER as part of the event 2.5 “Preclinical studies of innovative medicines” federal target program “Development of the Pharmaceutical and Medical Industry of the Russian Federation for the period till 2020 year and beyond “on the topic:” Preclinical studies of analgesic drug for oral use on the basis of an analog of the endogenous opioid peptide associated with oligoargininovym vector “(Code 2015-14-N08-0028).

Coauthors – CJSC “INPTS” Peptogen “, Moscow; Medical University Spbgmu them. IP Pavlov’s Ministry of Health, St. Petersburg.

Implementation of the project: Phase 3 (intermediate).

5. Government contracts from “23” October 2015 №14.N08.12.0050 with the Russian Ministry of Education to conduct PNIER as part of the event 2.5 “Preclinical studies of innovative medicines” of the federal target program “Development of the Russian Federation for the period up to 2020 the pharmaceutical and medical industry year and beyond “on the subject:” Pre-clinical studies of the drug peptide structure for correction of hypernatremia “(lot code number 2015-14-N08-0050).

Coauthors – CJSC “INPTS” Peptogen “, Moscow; IEFB Russian Academy of Sciences, St. Petersburg.

Implementation of the project: Phase 3 (intermediate).

6. Subcontractor Government contracts from “04” September 2015 № 14.N08.11.1036 with the Russian Ministry of Education to conduct PNIER as part of the event 2.5 “Preclinical studies of innovative medicines” federal target program “Development of the Pharmaceutical and Medical Industry of the Russian Federation for the period up to 2020 and beyond “on the topic:” Preclinical studies anticoagulant drug based on fucoidan “(Code 2015-14-N08-0036).

The main performer – Murmansk Marine Biological Institute KSC RAS, Murmansk.

Implementation of the project: Phase 3 (intermediate).

7. Government contracts by “10” in May 2016 № 14.N08.12.0070 with the Russian Ministry of Education to conduct PNIER as part of the event 2.5 “Preclinical studies of innovative medicines” federal target program “Development of the Pharmaceutical and Medical Industry of the Russian Federation for the period till 2020 year and beyond “on the topic:” Preclinical studies based on glycosylated polypeptide drug to prevent the development of complications postgrippoznyh “(Code 2016-14-N08-0002).
Implementation of the project: Phase 2 (intermediate).
8. Government contracts on “25” August 2016 № 14.N08.11.0099 with the Russian Ministry of Education to conduct PNIER as part of the event 2.5 “Preclinical studies of innovative medicines” federal target program “Development of the Pharmaceutical and Medical Industry of the Russian Federation for the period till 2020 year and beyond “on the subject:” Pre-clinical trials of medicinal products on the basis of FPR2 agonist of the receptor and the peptide inhibitor of the dipeptidyl peptidase 4 types for the treatment of diabetes mellitus type II “(Code 2016-14-N08-0025).
Implementation of the project: Phase 1 (intermediate).